Exelixis (EXEL) Depreciation and Depletion (2016 - 2021)
Exelixis (EXEL) recorded quarterly Depreciation and Depletion of $3.0 million in Q1 2021, up 42.86% quarter-over-quarter from $2.1 million in Q3 2019.
Exelixis (EXEL) Depreciation and Depletion (2016 - 2021) Analysis & Trends
Exelixis' Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $3.0 million for Q1 2021.
- In Q1 2021, Depreciation and Depletion changed N/A year-over-year to $3.0 million; the TTM figure through Jan 2021 stood at $9.1 million (changed N/A YoY), while the FY2023 annual figure was $25.7 million, up 22.97% from the prior year.
- Depreciation and Depletion was $3.0 million for Q1 2021 at Exelixis, up from $2.1 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $3.0 million in Q1 2021 to a low of $300000.0 in Q1 2017.
- Historically, Depreciation and Depletion has averaged $1.3 million across 4 years, with a median of $1.2 million in 2018.
- The sharpest annual moves came in 2017 and 2018: Depreciation and Depletion changed 0.0% in 2017, then surged 466.67% in 2018.
- A 4-year view of Depreciation and Depletion shows it stood at $400000.0 in 2017, then jumped by 400.0% to $2.0 million in 2018, then advanced by 5.0% to $2.1 million in 2019, then surged by 42.86% to $3.0 million in 2021.
- The last three Depreciation and Depletion figures came in at $3.0 million (Q1 2021), $2.1 million (Q3 2019), and $2.0 million (Q2 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1,395.22 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Exelixis | 13.71 Bn | 12.93 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 1, 2021 | 3.00 Mn |
| Jan 1, 2021 | 3.00 Mn |
| Sep 27, 2019 | 2.10 Mn |
| Sep 27, 2019 | 2.10 Mn |
| Jun 28, 2019 | 2.00 Mn |
| Jun 28, 2019 | 2.00 Mn |
| Mar 29, 2019 | 2.00 Mn |
| Mar 29, 2019 | 2.00 Mn |
| Dec 28, 2018 | 2.00 Mn |
| Dec 28, 2018 | 2.00 Mn |
| Sep 28, 2018 | 1.70 Mn |
| Sep 28, 2018 | 1.70 Mn |
| Jun 29, 2018 | 800,000.00 |
| Jun 29, 2018 | 800,000.00 |
| Mar 30, 2018 | 400,000.00 |
| Mar 30, 2018 | 400,000.00 |
| Dec 29, 2017 | 400,000.00 |
| Dec 29, 2017 | 400,000.00 |
| Sep 29, 2017 | 300,000.00 |
| Sep 29, 2017 | 300,000.00 |